'Unjustly punished in sell-off last year'
7IM's Peter Sleep comments on developments
AB Bernstein report
Growth becoming harder to achieve
As revealed by Cantor Fitzgerald Europe
Focused on companies making a social impact
New data from UBS
Scientific breakthroughs the key driver
Valuations remain high
Step closer to repealing Obamacare
'Highly selective approach'
Large acquisitions due
More support needed for UK innovation
QuotedData monthly roundup
Criticised pricing policies
In the third part of a short series, managers tell Investment Week which value plays still look attractive after a strong run this year.
Tides change for India and China
2016 saw several blow-ups for large drug companies
New products, strong finances and robust growth were the main talking points at JP Morgan's recent healthcare conference in San Francisco. There were positive signals regarding the fundraising climate, as well as the strength of innovation within the...
Opportunities in a number of sectors
Valentine's Day special
'Secure growth companies could be toppled by turnaround stories'
Likes healthcare and technology